Used as a key intermediate in the synthesis of biologically active quinazoline derivatives, particularly in pharmaceutical research targeting kinase inhibitors. Its structure supports the development of compounds with potential anticancer, anti-inflammatory, and antimicrobial properties. The bromo and methoxy functional groups allow for selective cross-coupling reactions, enabling efficient derivatization in medicinal chemistry programs. Commonly employed in the preparation of small-molecule drug candidates undergoing preclinical evaluation.